Fundraising Fox
Philip D. Greenberg
InvestorVenture Partner at Catalio Capital Management, LP
United States
Writes $100K – $5M checks · typically $1.5M
Find your path to Philip
Sign up to see every warm intro you have to Philip
- Paths you didn't know you had: your email and LinkedIn already hold routes to Philip. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Philip D. Greenberg is a Professor of Oncology and Immunology at the University of Washington and an Investigator at the Parker Institute for Cancer Immunotherapy at Fred Hutchinson Cancer Research Center. His work spans immunology, immuno-oncology, cancer biology, genetic engineering, and cell therapy. He earned a BA from Washington University in St. Louis and an MD from the State University of New York, and completed his residency and postdoctoral fellowship at the University of California, San Diego.
Invests in
BiotechHealthtech
Investments
Investor
Affini-T TherapeuticsFlowDeployJuno TherapeuticsTargeted Genetics
Sources: the firm's website · curated public sources.
Colleagues at Catalio Capital Management, LP
Frequently asked questions
- Who is Philip D. Greenberg?
- Philip D. Greenberg is a Professor of Oncology and Immunology at the University of Washington and an Investigator at the Parker Institute for Cancer Immunotherapy at Fred Hutchinson Cancer Research Center. His work spans immunology, immuno-oncology, cancer biology, genetic engineering, and cell therapy. He earned a BA from Washington University in St. Louis and an MD from the State University of New York, and completed his residency and postdoctoral fellowship at the University of California, San Diego.
- Where does Philip D. Greenberg work?
- Philip D. Greenberg is Venture Partner at Catalio Capital Management, LP.
- What does Philip D. Greenberg invest in?
- Philip D. Greenberg invests in Biotech, Healthtech.
- What check size does Philip D. Greenberg write?
- Philip D. Greenberg typically writes checks of $100K – $5M.
- What companies has Philip D. Greenberg invested in?
- Investments tracked here include Affini-T Therapeutics, FlowDeploy, Juno Therapeutics, Targeted Genetics.
About this profile. Compiled from public sources — Catalio Capital Management, LP's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights